Anti-inflammatory agents like enetercept (a TNFα inhibitor approved for several types of arthritis) have been suggested to treat Alzheimer’s disease (Decourt et al., 2017). This evidence concerns the gene TNF and early-onset autosomal dominant Alzheimer disease.